Evaluation of blood count parameters and their association with VTE in the Vienna Cancer and Thrombosis Cohort (N = 988 patients with solid tumors only)
ESAs indicates erythropoiesis-stimulating agents.
*75th percentile: 14 mg/dL.
†Adjusted for the other 2 blood cell variables (continous specification).
‡Khorana cutoff adjusted for the other 2 blood cell variables specified by Khorana cutoff.
§75th percentile: 9.23 G/L.
‖75th percentile: 308 × 109/L.
¶75th percentile: 4.7 × 1012/L.
#Adjusted for platelet count and WBC (continuous specification).
**Calculated using Cox proportional hazards regression.
††Calculated using Fine and Gray proportional subhazards regression incorporating death from any cause except due to fatal VTE as a competing end point.
